Preparation method of absorbable sericin suture line
By optimizing the sericin extraction and purification process, combining biocompatibility enhancer and nanomineral filler, the problems of complex sericin suture extraction process and chemical crosslinking agent residues are solved, and the mechanical properties of the suture are improved and Biocompatibility reduces inflammatory response, achieving more efficient wound healing and safe clinical applications.
Patent Information
- Application Number
- CN202411172578.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-08
AI Technical Summary
During the preparation of sericin absorbable sutures, the extraction and purification process is complex and time-consuming, affecting the mechanical properties and degradation characteristics, and the residue of chemical crosslinking agents may cause biocompatibility problems such as tissue inflammation or allergic reactions, limiting the Its large-scale application and certainty of clinical effects.
Using an optimized sericin extraction and purification process, biocompatibility enhancer, nanomineral filler and bioactive peptide were added, and crosslinker residue scavenger was used before forming to improve purity through multi-stage filtration and centrifugation techniques. Control pH and temperature, use hyaluronic acid, dexamethasone, nano-hydroxyapatite and RGD peptides and other ingredients, combined with ethylene glycol and water washing solution to reduce crosslinking agent residues and improve biocompatibility and mechanical properties.
Significantly improves the mechanical strength and degradation properties of sericin absorbable sutures, reduces biocompatibility problems, improves the reliability and safety of clinical applications, accelerates the wound healing process, and provides a safer and more effective surgical suture material.
Smart Images

Figure CN118903522A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of sericin absorbable sutures, and in particular to a method for preparing sericin absorbable sutures. Background Art
[0002] Absorbable sericin sutures are a type of biomaterial made from natural sericin with good biocompatibility and mechanical properties. Its main advantage is that it can be gradually degraded and absorbed in the body, avoiding the need for secondary surgery to remove the sutures, so it is widely used in various surgical operations. This type of suture can be gradually degraded into harmless small molecules through hydrolysis reactions in the body and eventually completely absorbed by the human body.
[0003] There are some technical defects and challenges in the preparation of sericin absorbable sutures. The extraction and purification process of sericin is relatively complex and time-consuming, and is easily affected by the source of raw materials and processing conditions, resulting in inconsistent purity and quality of the extracted protein. This inconsistency may affect the mechanical properties and degradation characteristics of the final suture. In the process of forming sericin into sutures, some chemical cross-linking agents may be required to enhance its mechanical properties, but the residues of these cross-linking agents may cause biocompatibility issues, such as local tissue inflammatory reactions or allergic reactions. These defects in the preparation process limit the large-scale application of sericin absorbable sutures and bring certain uncertainties to their clinical effects. Summary of the invention
[0004] In view of the shortcomings of the prior art, the present invention provides a method for preparing a sericin absorbable suture, which solves the problem that the extraction and purification process of sericin is relatively complicated and time-consuming, which will affect the mechanical properties and degradation characteristics of the final suture; in the process of forming sericin into sutures, some chemical cross-linking agents may need to be used to enhance its mechanical properties, but the residues of these cross-linking agents may cause biocompatibility problems, such as local tissue inflammatory reactions or allergic reactions.
[0005] To achieve the above objectives, the present invention is implemented through the following technical solutions: A sericin absorbable suture thread comprises the following components and their mass percentage contents:
[0006] Sericin: 55%-75%;
[0007] Biocompatibility enhancer: 10% to 20%;
[0008] Anti-inflammatory or anti-allergic agents: 2% to 6%;
[0009] Cross-linking agent residue scavenger: 1% to 3%;
[0010] Nano mineral filler: 3% to 8%;
[0011] Bioactive peptides: 0.5%~2%.
[0012] Preferably, the biocompatibility enhancer in the suture is hyaluronic acid, the molecular weight of the hyaluronic acid is in the range of 200 kDa to 500 kDa, the anti-inflammatory agent is dexamethasone or its derivatives, the antiallergic agent is chlorpheniramine or its derivatives, the cross-linking agent residue scavenger is ethylene glycol or water lotion, and the pH value is controlled in the range of 7.0 to 8.5.
[0013] Preferably, the nano mineral filler is nano hydroxyapatite, which is used to increase the mechanical strength of the suture and promote the healing of bone tissue, the bioactive peptide is RGD peptide, which is used to promote cell adhesion and accelerate tissue regeneration, and the suture further contains vitamin C or other antioxidants to reduce oxidative stress and promote collagen production during the healing process.
[0014] A method for preparing a sericin absorbable suture comprises the following steps:
[0015] A. Primary extraction of sericin: degumming silk waste to obtain primary sericin;
[0016] B. Optimize dissolution extraction: dissolve the primary sericin in a solution at a specific temperature and pH value, and use hydrolase to perform enzymatic hydrolysis to improve extraction efficiency and shorten extraction time;
[0017] C. Purification and concentration: Purify the sericin solution through multi-stage filtration and centrifugation technology to remove impurities, obtain high-purity sericin, and concentrate it;
[0018] D. Addition of biocompatibility enhancer: adding a biocompatibility enhancer to the purified sericin, wherein the enhancer is hyaluronic acid, and the molecular weight of the hyaluronic acid is controlled between 200 kDa and 500 kDa;
[0019] E. Mixing of anti-inflammatory agents and anti-allergic agents: dexamethasone or its derivatives as anti-inflammatory agents and chlorpheniramine or its derivatives as anti-allergic agents are uniformly mixed into the sericin solution to reduce inflammatory reactions or allergic reactions after suture implantation;
[0020] F. Addition of nano-mineral fillers: Nano-hydroxyapatite is added as a nano-mineral filler into the sericin solution to increase the mechanical strength of the suture and promote the healing of bone tissue;
[0021] G. Introduction of bioactive peptides: Adding RGD peptide to the mixed solution promotes cell adhesion and accelerates tissue regeneration;
[0022] H. Treatment of cross-linking agent residue scavenger: Before molding, use ethylene glycol or water washing liquid with pH value controlled at 7.0-8.5 to treat the mixed solution to remove possible chemical cross-linking agent residues;
[0023] I. Forming of suture: preparing the treated sericin solution into sericin suture by spinning or other forming processes;
[0024] J. Drying of sutures: Dry the formed sutures at low temperatures to maintain their mechanical properties and biocompatibility;
[0025] K. Antioxidant coating: Apply vitamin C or other antioxidants to the dried sutures to reduce oxidative stress and promote collagen production during the healing process;
[0026] L. Finished product testing and packaging: The finished sutures are tested for performance and packaged after ensuring they meet the standards.
[0027] Preferably, in step A, an alkaline solution is used for degumming to improve the extraction efficiency of sericin, and in step B, the pH value of the dissolving solution is controlled between 8.5 and 9.5 to ensure complete dissolution of the sericin.
[0028] Preferably, in step C, the purity of sericin is further improved by ultrafiltration membrane, and the biocompatibility enhancer in step D includes chitosan in addition to hyaluronic acid to further enhance biocompatibility.
[0029] Preferably, in step E, the ratio of the anti-inflammatory agent to the antiallergic agent is a mass ratio of dexamethasone to chlorpheniramine of 1:1 to 2:1m, and in step F, the particle size of the nano mineral filler is controlled at 20 to 50 nanometers to optimize the mechanical properties of the suture.
[0030] Preferably, the concentration of the bioactive peptide in step G is controlled between 0.1% and 0.5% to achieve the best cell promotion effect, and the molding step in step I adopts a wet spinning process to ensure the uniformity and mechanical properties of the suture.
[0031] The present invention provides a method for preparing a sericin absorbable suture, which has the following beneficial effects:
[0032] The method for preparing absorbable sericin sutures proposed by the present invention has significant advantages and solves many key problems in the prior art. First, by adopting an optimized sericin extraction and purification process, the extraction efficiency and purity of sericin are significantly improved, overcoming the problem of complex and time-consuming extraction process in traditional methods. This improvement ensures that the final prepared suture has higher mechanical strength and stable degradation characteristics, thereby improving the reliability of the suture in clinical applications.
[0033] In addition, the present invention introduces innovative ingredients such as biocompatibility enhancers, nano-mineral fillers and bioactive peptides in the preparation process of the suture, further improving the performance of the suture. In particular, by treating the chemical cross-linking agent residues before the suture is formed, the biocompatibility problems that may be caused, such as local tissue inflammation or allergic reactions, are reduced. Overall, the technical solution of the present invention not only improves the biocompatibility and mechanical properties of the suture, but also accelerates the healing process of the wound, providing a safer and more effective surgical suture material. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 It is a flow chart of the present invention. DETAILED DESCRIPTION
[0035] The technical solutions in the embodiments of the present invention are described clearly and completely. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0036] like Figure 1 As shown, an embodiment of the present invention provides a sericin absorbable suture, comprising the following components and their mass percentage contents:
[0037] Sericin: 55% to 75%, biocompatibility enhancer: 10% to 20%, anti-inflammatory agent or anti-allergic agent: 2% to 6%, cross-linking agent residue scavenger: 1% to 3%, nano mineral filler: 3% to 8%, bioactive peptide: 0.5% to 2%, the biocompatibility enhancer in the suture is hyaluronic acid, the molecular weight of hyaluronic acid ranges from 200 kDa to 500 kDa, the anti-inflammatory agent is dexamethasone or its derivatives, the anti-allergic agent is chlorpheniramine or its derivatives, the cross-linking agent residue scavenger is ethylene glycol or water wash solution, and the pH value is controlled within the range of 7.0 to 8.5, the nano mineral filler is nano hydroxyapatite, which is used to increase the mechanical strength of the suture and promote the healing of bone tissue, the bioactive peptide is RGD peptide, which is used to promote cell adhesion and accelerate tissue regeneration, and the suture further contains vitamin C or other antioxidants to reduce oxidative stress and promote collagen production during the healing process.
[0038] A method for preparing a sericin absorbable suture comprises the following steps:
[0039] A. Primary extraction of sericin: degumming silk waste to obtain primary sericin, which is then degummed using an alkaline solution to improve the extraction efficiency of sericin.
[0040] B. Optimize dissolution and extraction: Dissolve the primary sericin in a solution at a specific temperature and pH value, and use hydrolase to perform enzymatic hydrolysis to improve the extraction efficiency and shorten the extraction time. The pH value of the dissolving solution is controlled between 8.5 and 9.5 to ensure the complete dissolution of the sericin.
[0041] C. Purification and concentration: The sericin solution is purified through multi-stage filtration and centrifugation technology to remove impurities and obtain high-purity sericin. The sericin is then concentrated and the purity of the sericin is further improved through ultrafiltration membrane.
[0042] D. Addition of biocompatibility enhancer: Add biocompatibility enhancer to the purified sericin. The enhancer is hyaluronic acid. The molecular weight of hyaluronic acid is controlled between 200 kDa and 500 kDa. In addition to hyaluronic acid, the biocompatibility enhancer also includes chitosan to further enhance biocompatibility.
[0043] E. Mixing of anti-inflammatory agents and anti-allergic agents: Dexamethasone or its derivatives as anti-inflammatory agents and chlorpheniramine or its derivatives as anti-allergic agents are uniformly mixed into the sericin solution to reduce inflammatory or allergic reactions after suture implantation. The ratio of the anti-inflammatory agent to the anti-allergic agent is a mass ratio of dexamethasone to chlorpheniramine of 1:1 to 2:1m.
[0044] F. Addition of nano-mineral fillers: Nano-hydroxyapatite is added to the sericin solution as a nano-mineral filler to increase the mechanical strength of the suture and promote the healing of bone tissue. The particle size of the nano-mineral filler is controlled at 20 to 50 nanometers to optimize the mechanical properties of the suture.
[0045] G. Introduction of bioactive peptides: RGD peptide is added to the mixed solution to promote cell adhesion and accelerate tissue regeneration. The concentration of bioactive peptides is controlled between 0.1% and 0.5% to achieve the best cell promotion effect.
[0046] H. Treatment with cross-linking agent residue remover: Before molding, use ethylene glycol or water washing solution with a pH value controlled at 7.0-8.5 to treat the mixed solution to remove possible chemical cross-linking agent residues.
[0047] I. Forming of suture: The treated sericin solution is subjected to spinning or other forming processes to prepare sericin suture. The forming step adopts a wet spinning process to ensure the uniformity and mechanical properties of the suture.
[0048] J. Drying of sutures: Dry the formed sutures at low temperatures to maintain their mechanical properties and biocompatibility.
[0049] K. Antioxidant Coating: Dried sutures are coated with vitamin C or other antioxidants to reduce oxidative stress and promote collagen production during the healing process.
[0050] L. Finished product testing and packaging: The finished sutures are tested for performance and packaged after ensuring they meet the standards.
[0051] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A sericin absorbable suture, characterized in that: Includes the following ingredients and their mass percentage content: Sericin: 55%-75%; Biocompatibility enhancer: 10% to 20%; Anti-inflammatory or anti-allergic agents: 2% to 6%; Cross-linking agent residue scavenger: 1% to 3%; Nano mineral filler: 3% to 8%; Bioactive peptides: 0.5%~2%.
2. The absorbable sericin suture according to claim 1, characterized in that: The biocompatibility enhancer in the suture is hyaluronic acid, the molecular weight of the hyaluronic acid is in the range of 200 kDa to 500 kDa, the anti-inflammatory agent is dexamethasone or its derivatives, the antiallergic agent is chlorpheniramine or its derivatives, the cross-linking agent residue scavenger is ethylene glycol or water lotion, and the pH value is controlled in the range of 7.0 to 8.
5.
3. The absorbable sericin suture according to claim 1, characterized in that: The nano mineral filler is nano hydroxyapatite, which is used to increase the mechanical strength of the suture and promote the healing of bone tissue. The bioactive peptide is RGD peptide, which is used to promote cell adhesion and accelerate tissue regeneration. The suture further contains vitamin C or other antioxidants to reduce oxidative stress and promote collagen production during the healing process.
4. A method for preparing a sericin absorbable suture, characterized in that: The following steps are involved: A. Primary extraction of sericin: degumming silk waste to obtain primary sericin; B. Optimize dissolution extraction: dissolve the primary sericin in a solution at a specific temperature and pH value, and use hydrolase to perform enzymatic hydrolysis to improve extraction efficiency and shorten extraction time; C. Purification and concentration: Purify the sericin solution through multi-stage filtration and centrifugation technology to remove impurities, obtain high-purity sericin, and concentrate it; D. Addition of biocompatibility enhancer: adding a biocompatibility enhancer to the purified sericin, wherein the enhancer is hyaluronic acid, and the molecular weight of the hyaluronic acid is controlled between 200 kDa and 500 kDa; E. Mixing of anti-inflammatory agents and anti-allergic agents: dexamethasone or its derivatives as anti-inflammatory agents and chlorpheniramine or its derivatives as anti-allergic agents are uniformly mixed into the sericin solution to reduce inflammatory reactions or allergic reactions after suture implantation; F. Addition of nano-mineral fillers: Nano-hydroxyapatite is added as a nano-mineral filler into the sericin solution to increase the mechanical strength of the suture and promote the healing of bone tissue; G. Introduction of bioactive peptides: Adding RGD peptide to the mixed solution promotes cell adhesion and accelerates tissue regeneration; H. Treatment of cross-linking agent residue scavenger: Before molding, use ethylene glycol or water washing liquid with pH value controlled at 7.0-8.5 to treat the mixed solution to remove possible chemical cross-linking agent residues; I. Forming of suture: preparing the treated sericin solution into sericin suture by spinning or other forming processes; J. Drying of sutures: Dry the formed sutures at low temperatures to maintain their mechanical properties and biocompatibility; K. Antioxidant coating: Apply vitamin C or other antioxidants to the dried sutures to reduce oxidative stress and promote collagen production during the healing process; L. Finished product testing and packaging: The finished sutures are tested for performance and packaged after ensuring they meet the standards.
5. The method for preparing a sericin absorbable suture according to claim 1, characterized in that: In step A, an alkaline solution is used for degumming to improve the extraction efficiency of sericin. In step B, the pH value of the dissolving solution is controlled between 8.5 and 9.5 to ensure complete dissolution of sericin.
6. The method for preparing a sericin absorbable suture according to claim 1, characterized in that: In the step C, the purity of sericin is further improved by ultrafiltration membrane, and the biocompatibility enhancer in the step D includes chitosan in addition to hyaluronic acid to further enhance biocompatibility.
7. The method for preparing a sericin absorbable suture according to claim 1, characterized in that: In the step E, the ratio of the anti-inflammatory agent to the anti-allergic agent is a mass ratio of dexamethasone to chlorpheniramine of 1:1 to 2:1m. In the step F, the particle size of the nano mineral filler is controlled at 20 to 50 nanometers to optimize the mechanical properties of the suture.
8. The method for preparing a sericin absorbable suture according to claim 1, characterized in that: The concentration of the bioactive peptide in step G is controlled between 0.1% and 0.5% to achieve the best cell promotion effect. The molding step in step I adopts a wet spinning process to ensure the uniformity and mechanical properties of the suture.
Citation Information
Cited By
Fibroin-containing absorbable suture line and preparation method thereof
CN120939272A
Absorbable suture containing silk fibroin and method for preparing the same
CN120939272B
Medical suture residue detection method and system
CN122545553A
A method and system for detecting medical suture remnants
CN122545553B
